ReadYourDNA

Dapsone

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Dapsone

What it is

Dapsone is an antibacterial of the sulfone family that also calms some kinds of inflammation. It is used, with other medicines, to treat leprosy, to prevent Pneumocystis pneumonia in people with weakened immunity, for the itchy skin condition dermatitis herpetiformis, and as a gel for acne. It is sold under several names, including Aczone for the gel.

How genes come into it

G6PD protects red blood cells from chemical stress. People with G6PD deficiency, common in people of African, Mediterranean, Middle Eastern and South Asian ancestry and more often in men because the gene is on the X chromosome, are at higher risk of haemolysis, the breakdown of red blood cells, when taking dapsone. CPIC has published a guideline on G6PD that covers dapsone, and the US label mentions it. Separately, HLA-B*13:01, most common in Asian populations, is linked to a rare severe hypersensitivity reaction.

Published guidelines

Clinical guidelines that name a gene for Dapsone. They sort people into groups by the gene copies they carry.

CPIC guideline: G6PD. Normal · Indeterminate · Deficient with CNSHA · Variable · Deficient. Strong. 2023.

US FDA: G6PD. Deficient · Deficient with CNSHA · Variable. 2018.

What research found

Every published finding on gene variants and Dapsone. Upload your DNA file to see which of these rows apply to you.

Rated evidence (8 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

HLA-B HLA-B*13:01: Level 2A · replicated. Toxicity: Drug Hypersensitivity, Drug Reaction with Eosinophilia and Systemic Symptoms, Leprosy, Maculopapular Exanthema, Severe Cutaneous Adverse Reactions, Stevens-Johnson Syndrome. 6.

HLA-B HLA-B*15:02: Level 3. Toxicity: Severe Cutaneous Adverse Reactions, Stevens-Johnson Syndrome. 1.

HLA-DRB1 rs701829: Level 3. Toxicity: Drug Hypersensitivity. 1.

HLA-DRB1 rs17211071: Level 3. Toxicity: Drug Hypersensitivity. 1.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Bactrim (Sulfonamides)

Sulfamethoxazole (Sulfonamides)

Actemra (IL-6 Inhibitors)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com